The Pharmacology of Heart Failure

The Pharmacology of Heart Failure

The Pharmacology of Heart Failure with Reduced Ejection Fraction (HFrEF) CHRONIC AND ACUTE A N I T A R A L S T I N, M S , C N S , B C , C N P - B C I have no conflicts of interest. HFrEF vs HFpEF Left ventricular failure with reduced EF is now noted as HFrEF (heart failure with

reduce ejection fraction) Previous diastolic heart failure is now noted as HFpEF (heart failure with preserved ejection fraction) Impact of Heart Failure (HF) Approximately 4.6 million American are living with heart failure. Annual number diagnosed: 450,000 Mortality: decreasing, but remains high Researchers predict > 8 million by 2030 2012 direct cost for HF was $20.9 billion,

projected to be $53 billion by 2030 Heart Failure Society of America; ; K. Fitch, P Pelizzari, B Pyenson; The High Cost of Heart Failure for the Medicare Population: An Actuarial Cost Analysis 2/2015 Complex Pathophysiology of HF The Frank-Starling mechanism, in which an increased preload helps to sustain cardiac performance Alterations in myocyte regeneration and death Myocardial hypertrophy with or without cardiac

chamber dilatation, in which the mass of contractile tissue is augmented Activation of neurohumoral system Norepinephrine release Activation of renin-angiotension-aldosterone system Activation of sympathetic nervous system Atrial natruetic peptide, vasopressin

Classification of HF New York Heart Classification I,II,III, IV ACC/AHA Stages Stage Stage Stage Stage

A B C D Stage A Pharmacology Prevention

Hypertension management CAD prevention Diabetes management Metabolic syndrome management Treat ETOH abuse Stage B Pharmacology Developed structural heart disease without symptoms of HF

Initiate ACE-I or ARB Initiate Beta Blocker therapy Aldosterone Blocking ACE-I/ARB Renin-angiotension-aldosterone system (RAAS) activation

Compensatory mechanism to maintain cardiac output Increasing evidence of local RAAS at the tissue level (heart, kidney and vasculature) Angiotension II is a potent vasoconstrictor, triggers SNS and adrenal release of aldosterone Ace Inhibitors were found to improve survival in CHF patients

Delay onset & progression of HF in pts with asymptomatic LV dysfunction cardiac remodeling Common ACE-I benazepril (Lotensin) captopril (Capoten) enalapril (Vasotec, Epaned) fosinopril (Monopril) lisinopril (Prinivil, Zestril) moexipril (Univasc) perindopril (Aceon)

quinapril (Accupril) ramipril (Altace) trandolapril (Mavik) ACE-I Side Effects Angioedema Hypotension Renal insufficiency Rash Cough Monitor renal function and potassium levels ARB

Considered equivalent to ACE-I Less cough due to reduced bradykinin release. Minimal evidence supporting using ACE-I and ARB together. Common ARBs Azilsartan (Edarbi) Candesartan (Atacand) Eprosartan Irbesartan (Avapro) Losartan (Cozaar)

Olmesartan (Benicar) Telmisartan (Micardis) Valsartan (Diovan) ARB Side Effects Less cough than ACE-I Similar SE profile as ACE-I Beta Blockers (BB) Reduce the effect of the sympathetic nervous system (beta receptors)

Reduce heart rate to allow improved left ventricular filling Some relax blood vessels to reduce afterload. Start with ACE-I/ARB as there is a synergic effect Start with low doses and advance. Approved BB for Heart Failure

Carvedilol Bisoprolol Metoprolol XL These have shown to slow progression of HF, prolong survival and reduce ventricular arrhythmias Side Effects of BB Feeling fatigued Hypotension Bradycardia Cold hands/feet

Worsening asthma s/s Hair loss Stage C Heart Failure Structural changes with s/s of heart failure Continue use of approved BB and ACE-I/ARB Add aldosterone blocking agent Replace ACE-I/ARB with valsartan/sacubitril (Entresto) Consider

ivabradine (Corlanor) Aldosterone Blockade Aldosterone has been shown to cause coronary inflammation, cardiac hypertrophy, myocardial fibrosis, ventricular arrhythmias, and ischemic lesions. Two medications spironolactone

eplerenone Indicated for those with EF 35% or less. Stage B or C. Do not use if CR 2.5 in men or 2.0 in women or potassium 5.0 or higher. Stop potassium supplementation, monitor and restart if needed. spironolactone Non-selective blocker leads to increased incidence of gynecomastia,

Dose 12.5 to 25 mg daily. May reduce dose to QOD for GFR 30-49. Monitor renal function and potassium levels at onset and 1 week post implementation, then monthly for first 3 moths. eplerenone Considered to be as potent as spironolactone. Dose 25 mg daily. May reduce dose to QOD for GFR 30-49. Monitor renal function and potassium levels

at onset and 1 week post implementation, then monthly for first 3 moths. Valsartan/sacubitril ARB (valsartan) is combined with an inhibitor of neprilysin, an enzyme that degrades natriuretic peptides, bradykinin, adrenomedullin, and other vasoactive peptides. In an RCT that compared the first approved ARNI, valsartan/sacubitril, with enalapril in symptomatic patients with HFrEF tolerating an adequate dose of either ACE inhibitor or ARB, the ARNI reduced the composite endpoint of

cardiovascular death or HF hospitalization significantly, by 20% C. Yancy, 2016 ACC/AHA/HFSA Guideline for the Management of Heart Failure Valsartan/sacubitril On ACE-I/ARB Allow 36 hour washout Start at 49/51 BID dose Not on ACE-I/ARB or severe renal impairment

Start at 24/26 BID Increase every 2-4 weeks to target maintenance dose of 97/103 BID Side Effects valsartan/sacubitril Hypotension Impaired renal function Angioedema Hyperkalemia Cost

$12.50/day; $4500/year ivabradine (Corlanor) Indications: heart rate reduction Corlanor (ivabradine) is a hyperpolarizationactivated cyclic nucleotide-gated channel blocker indicated to reduce the risk of hospitalization for worsening heart failure in patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction

35%, who are in sinus rhythm with resting heart rate 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use Corlaor Prescribing Information 1/2017 ivabradine (Corlanor) Up titrate BB first. For patients on maximum tolerated medical therapy with sinus rhythm and resting heart rate > 70 BPM. Initiate at 5 mg BID, assess at 2 weeks and

up titrate to 7.5 mg BID to maintain resting HR between 50-60 BPM Reduce dose to 2.5 mg BID or stop medication if resting HR < 50 BPM ivabradine (Corlanor) Contraindications

Acute decompensated HF BP < 90/50 SSS, AV Block unless pacemaker in place Sinus bradycardia Use with strong CYP3A4 inhibitors -incomplete list Alprazolam, carbamazepine, colchicine, cyclosporine, dexamethasone, disopyramide, fluticasone, lovastatin, repaglinide, sildenafil, simvastatin, tadalafil, triazolam ivabradine (Corlanor) Side Effects

Fetal toxicity Atrial fibrillation Bradycardia and conduction disturbances Syncope Ventricular arrhythmias Cost About $375/month Diuretics Used for fluid volume management Use lifestyle changes to reduce the

dependence on diuretics. Loop diuretics are most effective. furosemide torsemide bumetanide Pearls for Diuretics If loosing effectiveness, switch to another

loop for a time Add metolazone 2.5 to 5 mg PO 30 minutes before diuretic dose. Educate the patient on s/s of dehydration Prescribe just a few tablets Monitor and replace potassium and magnesium.

Digoxin May be considered in HF patients to reduce hospitalization. Narrow therapeutic window Toxicity Anorexia

Nausea, vomiting Headache Disorientation. Vasodilators Reduction of afterload by arteriolar vasodilatation (hydralazine) reduce LVEDP, O2 consumption, improve myocardial perfusion, stroke volume and COP Reduction of preload By venous dilation (nitrate) the venous return the load on both ventricles.

Usually the maximum benefit is achieved by using agents with both action. Use when intolerant to ACE-I/ARB. Vasodilators Monitor BP and renal function. Headache common SE of nitrates and hydralazine. Hydralazine also can cause nausea, vomiting, diarrhea and orthostatic hypotension. Stage D

End stage heart failure Medications continue as long as HR and BP can be sustained. Wean medications when BP cannot be sustained. Consider advanced heart failure therapies or inotropic support. Acute Decompensated Heart Failure Common and potentially fatal Maintain outpatient HF medications as possible Usually present with acute dyspnea from

pulmonary edema Can also present with signs of low output: fatigue, marked exercise intolerance, anorexia, cognitive impairment Acute Decompensated Heart Failure Treatment Goals Goals

Hemodynamic stabilization Support oxygenation and ventilation Symptom relief Modalities Diuresis Supplemental oxygen and assisted ventilation

Vasodilator therapy in some patients Inotropes Arrhythmia Management Diuresis and Vasodilation Mainstays of therapy Flash pulmonary edema with HTN Diuresis and aggressive vasodilation Normotensive and volume overload Diuresis and vasodilation

Hypotension and volume overload Diuresis +/- inotropes Aortic Stenosis Diuresis with caution Diuretics IV preferred over PO because of better bioavailability; bypasses GI congestion Common initial doses: furosemide 40 mg, bumetanide 1 mg, torsemide 10-20 mg

Rule of thumb: 1-2.5 times their normal PO dose Peak diuresis is 30 minutes after administration Bolus and continuous IV infusions have similar efficacy Adding a thiazide diuretic (metolazone) can potentiate the effects of the loop diuretics Vasodilators IV nitroglycerin or IV nitroprusside Monitor BP to make sure hypotension does not develop Nitrates are contraindicated with PDE-5

inhibitors like sildenafil Nitroprusside Dont titrate above 400 mcg/min of nitroprusside (cyanide toxicity) Can result in reflex tachycardia or rebound vasoconstriction Inotropes Consider if hypotensive with severe systolic

dysfunction Can lead to ischemia (increased HR and myocardial oxygen consumption) or arrhythmias Worse mortality if given to patients who do not critically need these meds Dobutamine and dopamine: primarily beta-1 agonists

Milrinone: phosphodiesterase inhibitor Dopamine Dobutamine Can be used at low dose to improve renal blood flow if diuresis is not adequate. For cardiogenic shock, inotropes are used to support sufficient blood flow to preserve organ function. Dopamine to improve cardiac contractility, initiate at 5-10 mcg/kg/min IV Dobutamine has less MVO2 demand, may result in tachycardia. 0.5-1 mcg/kg/min IV

Norepinephrine Catecholamine with alpha receptor activity (vasoconstriction) to treat hypotension Increases afterload which could reduce cardiac output. Increases myocardial oxygen consumption. Dose for acute hypotension Initial 8-12 mcg/min IV and titrate to effect

Maintenance 2-4 mcg/min IV Milrinone A selective phosphodiesterase inhibitor in cardiac and vascular tissue. Positive inotropic and vasodilator effects. Dose 50 mcg/kg loading dose by IV push over 10 minutes then 0.375-0.75 mcg/kg/min. Used in Stage D HF for symptom management as home infusion. Must demonstrate improvement in right heart pressures and symptoms to qualify.

Thank you, Questions?

Recently Viewed Presentations

  • Defining the Cyber Domain for Wireless Communications Security

    Defining the Cyber Domain for Wireless Communications Security

    Losing track of signs when adding up impedances. ... Perform all calculations using complex math. Transform resulting phasors back to time domain (if reqd). Series-Parallel Rules for AC Circuits. Similar to DC circuits we can apply the following rules to...
  • Pastor-Parish Relations Committee Training

    Pastor-Parish Relations Committee Training

    The pastor(s) and deacon(s) serving the church complete the . Clergy Self-Evaluation. Week Two: The lead pastor, church council chairperson, staff parish relations chairperson, finance chairperson, lay leader, and other clergy and leaders as appropriate (at least 5 persons) meet...
  • World War II - Mr. Colletti&#x27;s Online Classroom

    World War II - Mr. Colletti's Online Classroom

    World War II Starts ... III. German Blitzkrieg Cont. B. Allows the Nazis to move swiftly across Europe - taking Poland, Denmark, Norway, Luxemburg, Belgium, and the Netherlands all in just 8 weeks. ... The Maginot Line - A line...
  • Physics - St. Johns County School District

    Physics - St. Johns County School District

    A basic understanding of chemistry is central to all sciences: biology, physics, Earth science, ecology, etc. Branches of chemistry include: Organic Chemistry. Inorganic Chemistry. Physical Chemistry. ... About 40-60k for starting pay with B.S. and M.S. and 100k-200k for medical...
  • Imperative - Web German

    Imperative - Web German

    Imperative Deutsch für Anfänger Imperative The Imperative is the same as the Command form. The imperative form is only used with the 2nd person (singular and plural): du, Sie, ihr and with the 1st person plural: Wir Imperative Deutsch für...
  • CAMPBELL BIOLOGY IN FOCUS Urry  Cain  Wasserman  Minorsky

    CAMPBELL BIOLOGY IN FOCUS Urry Cain Wasserman Minorsky

    Figure 6.18 (b) Cooperativity: another type of allosteric. activation (a) Allosteric activators and inhibitors. Substrate. Inactive form. Stabilized. active form
  • Eastern Thought: Confucianism, Legalism, and Daoism

    Eastern Thought: Confucianism, Legalism, and Daoism

    Comparative: Daoism and Animism. Daoism is newer compared to Animism and it can traced back to a founder, while Animism is a belief that seemed to be found in multiple cultural hearths from the earliest of civilizations.
  • SS5H4 U.S. Involvement in World War I &

    SS5H4 U.S. Involvement in World War I &

    Jazz music developed among African Americans in the South, and quickly became popular all over the US. ... He worked faster than if he had to move around the car bolting on all the wheels. Henry Ford & Wife in...